Metabolic druggable proteome upregulated in cold tumors such as FASN, whose inhibitor (cerulenin) is a potential candidate for inhibiting tumor growth and simultaneously boosting TME function (Supplementary Fig. 9g). The gene discussed is FASN; the disease is neoplasm.